Correlation of HA-1 Disparity With Acute GVHD
| Skin Stage . | HA-1 Disparity (P = .02) . | |
|---|---|---|
| Absent . | Present . | |
| 0 | 124 (62) | 14 (41) |
| 1 | 5 (2) | 3 (9) |
| 2 | 26 (13) | 2 (6) |
| 3 | 42 (21) | 15 (44) |
| 4 | 4 (2) | 0 |
| Gut Stage | HA-1 Disparity (P = .0007) | |
| Absent | Present | |
| 0 | 154 (77) | 16 (47) |
| 1 | 29 (14) | 13 (38) |
| 2 | 8 (4) | 1 (3) |
| 3 | 5 (2) | 3 (9) |
| 4 | 5 (2) | 1 (3) |
| Liver Stage | HA-1 Disparity (P = .92) | |
| Absent | Present | |
| 0 | 152 (76) | 25 (74) |
| 1 | 18 (9) | 5 (15) |
| 2 | 16 (8) | 2 (6) |
| 3 | 10 (5) | 2 (6) |
| 4 | 5 (2) | 0 |
| Overall Grade | HA-1 Disparity (P = .04) | |
| Absent | Present | |
| 0 | 115 (57) | 12 (35) |
| II | 53 (26) | 15 (44) |
| III | 29 (14) | 7 (21) |
| IV | 4 (2) | 0 |
| Skin Stage . | HA-1 Disparity (P = .02) . | |
|---|---|---|
| Absent . | Present . | |
| 0 | 124 (62) | 14 (41) |
| 1 | 5 (2) | 3 (9) |
| 2 | 26 (13) | 2 (6) |
| 3 | 42 (21) | 15 (44) |
| 4 | 4 (2) | 0 |
| Gut Stage | HA-1 Disparity (P = .0007) | |
| Absent | Present | |
| 0 | 154 (77) | 16 (47) |
| 1 | 29 (14) | 13 (38) |
| 2 | 8 (4) | 1 (3) |
| 3 | 5 (2) | 3 (9) |
| 4 | 5 (2) | 1 (3) |
| Liver Stage | HA-1 Disparity (P = .92) | |
| Absent | Present | |
| 0 | 152 (76) | 25 (74) |
| 1 | 18 (9) | 5 (15) |
| 2 | 16 (8) | 2 (6) |
| 3 | 10 (5) | 2 (6) |
| 4 | 5 (2) | 0 |
| Overall Grade | HA-1 Disparity (P = .04) | |
| Absent | Present | |
| 0 | 115 (57) | 12 (35) |
| II | 53 (26) | 15 (44) |
| III | 29 (14) | 7 (21) |
| IV | 4 (2) | 0 |
Data indicate the n and (%) in each category. P values for differences in the distribution of skin, liver, and gut stages and overall grade were calculated from Wilcoxon rank sum tests.